Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen u.S. Plan — Benefits Paid to Participants ($M) ($M)
Form 11-K Amgen Retirement and Savings Plan (U.S.)
Latest, FY2025
641
Period ended Dec 31, 2025
Change on a year earlier
+19.5%
536 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Plan — Benefits Paid to Participants ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 641 | +19.5% | Form 11-K (Retirement & Savings Plan) (amgn-20260611.htm, filed 2026-06-11) ↗ |
| FY2024 | Dec 31, 2024 | 536 | +1.2% | Form 11-K (Retirement & Savings Plan) (a2024usplan11-k.htm, filed 2025-06-12) ↗ |
| FY2023 | Dec 31, 2023 | 530 | +22.2% | Form 11-K (Retirement & Savings Plan) (a2023usplan11-k.htm, filed 2024-06-21) ↗ |
| FY2022 | Dec 31, 2022 | 433 | -31.6% | Form 11-K (Retirement & Savings Plan) (a2022usplan11-k.htm, filed 2023-06-15) ↗ |
| FY2021 | Dec 31, 2021 | 633 | +36.8% | Form 11-K (Retirement & Savings Plan) (a2021usplan11-k.htm, filed 2022-06-24) ↗ |
| FY2020 | Dec 31, 2020 | 463 | – | Form 11-K (Retirement & Savings Plan) (a2020usplan11-k.htm, filed 2021-06-23) ↗ |
Cite this data
StockData. (2026). Amgen U.S. Plan — Benefits Paid to Participants ($M) ($M), annual FY2020–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/plan_us_benefits
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.